[HTML][HTML] COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
CL Maier, T Sarker, F Szlam, RM Sniecinski - Journal of Thrombosis and … - Springer
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
[引用][C] COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
CL Maier, T Sarker, F Szlam… - Journal of Thrombosis and …, 2021 - cir.nii.ac.jp
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by
thromboelastography | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
thromboelastography | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
CL Maier, T Sarker, F Szlam… - Journal of thrombosis …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography.
CL Maier, T Sarker, F Szlam… - Journal of Thrombosis …, 2021 - europepmc.org
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
[HTML][HTML] COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
CL Maier, T Sarker, F Szlam… - Journal of Thrombosis …, 2021 - ncbi.nlm.nih.gov
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
CL Maier, T Sarker, S Fania… - Journal of Thrombosis …, 2021 - search.proquest.com
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …